• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Panjon Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3368.0
  • ISIN : INE744D01019
17.98 0 (-0.11%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    17.64

  • Today’s High

    19.00

  • Open

    19.00

  • Perv Close

    18.00

  • 52W Low

    16.16

  • 52W High

    30.00

Key Indicators

  • P/E(TTM)

    49.94

  • Mar.Cap (₹Cr.)

    30.86

  • Div & Yield %

    0.00

  • Book Value(₹)

    9.92

  • Debt-Equity Ratio

    -0.11

  • AGM Date

    03-Nov-2026

  • EPS

    0.36

  • P/E Ratio

    49.94

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    30.86

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    17.16

  • BV (₹)

    9.90

  • Sales( ₹ in Cr.)

    47.62

  • NP (in Cr.)

    0.60

  • NP Var(%)

    51.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    30.90

  • 52 Week High

    30.00

  • 52 Week Low

    16.16

  • Price BSE

    18.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    30.90

  • P/C Ratio

    34.20

  • P/E Ratio

    51.50

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 30.46 12.55 6.09 8.43 14.54 26.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 30.46 12.55 6.09 8.43 14.54 26.43
Other Income 0.31 0.45 0.38 0.30 0.33 0.29
Stock Adjustments 0.27 0.21 -0.10 0.05 -0.08 0.07
Total Income 31.04 13.21 6.37 8.78 14.79 26.79
EXPENDITURE :            
Raw Materials 25.87 9.17 1.98 4.54 11.68 23.60
Power and Fuel Cost 0.08 0.07 0.07 0.08 0.10 0.16
Employee Cost 0.70 0.60 0.47 0.46 0.42 0.47
Other Manufacturing Expenses 0.02 0.02 0.03 0.02 0.18 0.28
Selling and Administration Expenses 3.11 2.69 3.15 3.05 1.50 1.52
Miscellaneous Expenses 0.31 0.22 0.30 4.38 0.39 0.14
Employee Benefit Expenses 0.70 0.60 0.47 0.46 0.42 0.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 30.08 12.77 6.00 12.52 14.27 26.18
Operating Profit 0.94 0.43 0.38 -3.74 0.52 0.61
Interest 0.18 0.06 0.05 0.07 0.10 0.15
Gross Profit 0.76 0.37 0.33 -3.81 0.42 0.46
Depreciation 0.23 0.22 0.21 0.20 0.23 0.27
Profit Before Tax 0.53 0.15 0.12 -4.01 0.19 0.19
Current Tax 0.08 0.02 0.02 0.02 0.02 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.02 -0.71 0.12 0.07 0.18
Reported Net Profit 0.40 0.15 0.81 -4.15 0.10 -0.03
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.40 0.15 0.81 -4.15 0.10 -0.03
Adjustment below Net Profit 0.01 0.00 0.01 0.00 -0.01 -0.01
P & L Balance brought forward -10.34 -10.50 -11.32 -7.17 -7.25 -7.21
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -9.93 -10.34 -10.50 -11.32 -7.17 -7.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.23 0.09 0.52 -2.68 0.06 -0.02
Earnings Per Share(Adj)-Unit Curr 0.23 0.09 0.52 -2.68 - -
Book Value 9.64 9.11 8.70 8.17 10.85 10.79
Book Value(Adj)-Unit Curr 9.64 9.11 8.70 8.17 - -

Shareholding Pattern

  • Promoter Group

    56.69%

  • Public Share Holding

    43.31%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,500,000 8.74 1,500,000 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,229,815 47.95 8,229,815 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,729,815 56.69 9,729,815 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 818,219 4.77 817,819 53
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 122,065 0.71 81,365 512
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 204,441 1.19 204,441 133
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,754,648 16.05 2,754,648 26
Individuals holding nominal share capital up to Rs. 1 lakh 3,520,534 20.51 3,219,571 9,504
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,000 0.01 2,000 2
Others 0 0.00 0 0
Sub Total 7,434,711 43.31 7,092,648 10,236
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 17,164,526 100.00 16,822,463 10,245

Company Background

Panjon LtdPharmaceuticals - Indian - Formulations

  • Panjon Ltd
  • BSE Code : 3368.0
  • ISIN : INE744D01019

  • Incorporation Year

    1983

  • Registered Office

    01 Panjon Farm House
    Airport Bijasan Road, Indore,
    Madhya Pradesh-452005

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Jay Kothari

  • Company Secretary

    Arpita Vijayvargiya

  • Auditor

    Goyal Parul & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Panjon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Panjon 17.98 30.77 30.46 49.94 2.55
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77